
It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

